FCF Life Sciences co-organizes “ACCESS CHINA Forum – Winter Online Partnering Weeks”
FCF co-organizes, together with its partner YAFO Capital, the “ACCESS CHINA Forum – Winter Online Partnering Weeks” which will be held online on January 4th-22nd, 2021. ACCESS CHINA is the most effective deal-making platform for
FCF Life Sciences Venture Capital Monitor – 10/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 10/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF European Infrastructure & Construction Market Study 2020 – published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Infrastructure & Construction Market Study – 2020”. Based on available data from European infrastructure and construction companies, the FCF Infrastructure & Construction
FCF Advanced Manufacturing Venture Capital Report – 2020 published
FCF Fox Corporate Finance GmbH is pleased to publish the “FCF Advanced Manufacturing Venture Capital Report – 2020”. The report is part of the “FCF DeepTech Series“, which is a quarterly series of reports tracking
FCF Bank Monitor – Q3 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Bank Monitor – Q3 2020”. FCF regularly engages in research on the banking sector based on available data from the most active and
FCF TMT Market Study 2020 – published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF TMT Market Study – 2020”.. Based on available data from European TMT companies, the FCF TMT Market Study is a detailed and comprehensive
FCF Fox Corporate Finance GmbH advises Immunic on financing the development of a potential COVID-19 drug
Gräfelfing/Munich, October 23rd, 2020 – FCF Fox Corporate Finance acts as advisor to Immunic, a biotechnology company specialized on immunology therapies, in the execution of a venture loan financing with the European Investment Bank (EIB).
FCF Valuation Monitor – Q3 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q3 2020”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
FCF Pharmaceutical Market Study – 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2020”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive
FCF Robotics Venture Capital Report – 2020 published
FCF Fox Corporate Finance GmbH is pleased to publish the “Robotics Venture Capital Report – 09/2020”. The report is part of the “FCF DeepTech Series”, which is a quarterly series of reports tracking European venture